Summary & Overview
HCPCS E2101: Blood Glucose Monitor with Integrated Lancing/Blood Sample
HCPCS Level II code E2101 identifies a blood glucose monitor with integrated lancing/blood sample capability. These devices combine the meter and lancet mechanism into a single unit, simplifying self-monitoring and point-of-care glucose testing for patients with diabetes and other conditions requiring glucose surveillance. Nationally, this code matters because it relates to a common, high-volume durable medical equipment category used across home and outpatient settings and intersects with chronic disease management programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage approaches and common claims considerations for DME glucose monitoring devices under these plans.
Readers will learn the clinical context for integrated glucose monitors, where they are typically supplied and used, and the operational elements relevant to claims processors and billing teams. The report provides benchmarks and coverage trends where available, explains common service settings, and highlights policy updates affecting device eligibility and billing practices. Data not available in the input is clearly noted where relevant.
Billing Code Overview
HCPCS Level II code E2101 denotes a blood glucose monitor with integrated lancing/blood sample. This device combines a glucose meter and an integrated lancing mechanism that collects the blood sample, streamlining point-of-care blood glucose testing.
Service Type: Durable medical equipment for blood glucose monitoring
Typical Site of Service: Home use or outpatient settings where self-monitoring or point-of-care glucose testing is performed, including patient residences and ambulatory clinics.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 58-year-old person with type 2 diabetes mellitus managed with oral agents and insulin, requiring a blood glucose monitor with integrated lancing and blood sample collection for self-monitoring of blood glucose (SMBG). The patient presents to a primary care clinic or diabetes education center where a clinician assesses the need for durable medical equipment. The clinician documents diagnosis, frequency of monitoring, and therapeutic rationale; places an order or prescription for a blood glucose monitor with integrated lancing (HCPCS E2101) to be dispensed by durable medical equipment suppliers or a pharmacy. The device is provided for home use; training on device operation, infection control, strip usage, and result interpretation is typically delivered by a diabetes educator or nurse during the visit. Follow-up visits or telehealth encounters review SMBG logs and adjust medication or insulin regimens. Typical sites of service include outpatient clinic, physician office, diabetes education center, and community pharmacy when dispensed directly to the patient.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / default | Use when no other modifier applies and the service is furnished as usual. |